Aprea Therapeutics
APRE
APRE
40 hedge funds and large institutions have $4.5M invested in Aprea Therapeutics in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 15 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
53% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 15
57% less capital invested
Capital invested by funds: $10.4M → $4.5M (-$5.86M)
Holders
40
Holding in Top 10
–
Calls
$1.11M
Puts
$23K
Top Buyers
| 1 | +$92K | |
| 2 | +$85.1K | |
| 3 | +$38K | |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$38K |
| 5 |
Two Sigma Investments
New York
|
+$35K |
Top Sellers
| 1 | -$1.25M | |
| 2 | -$636K | |
| 3 | -$308K | |
| 4 |
PP
PDT Partners
New York
|
-$211K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$160K |